| Angioplasty increases target site concentrations of ciprofloxacin in patients with peripheral arterial occlusive disease. | |
| | |
MedLine Citation:
|
PMID: 11753269 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: Patients with peripheral arterial occlusive disease are prone to soft tissue infections and frequently require antibiotics. To date, however, it is not known whether improvement of arterial blood flow by angioplasty of stenosis increases antibiotic concentrations in ischemic lesions. PATIENTS AND METHODS: All patients were scheduled to undergo elective percutaneous transluminal angioplasty (n = 10). Following a single, 400-mg dose of ciprofloxacin, drug concentrations in plasma, ischemic and healthy soft tissue; arterial peak systolic velocity; and ankle-brachial pressure index were assessed before and after angioplasty. Unbound ciprofloxacin concentrations were measured at the site of infection with use of in vivo microdialysis. RESULTS: Angioplasty increased peak systolic velocity and ankle-brachial pressure index compared with baseline (P <.002). Before angioplasty area under concentration-time curve (AUC(0-300)) values for ciprofloxacin were lower in ischemic tissue than in healthy tissue, with median values of 7.1 mg.h/L (range, 3.5-13.0) and 11.3 mg.h/L (range, 3.4-19.0), respectively (P =.03). After angioplasty AUC(0-300) values were identical in ischemic and healthy adipose tissue; median AUC(0-300) values were 8.0 mg.h/L (range, 4.0-20.7) and 8.5 mg.h/L (range, 4.4-22.9), respectively (P =.7). A combined in vivo pharmacokinetic/in vitro pharmacodynamic simulation based on tissue concentration data indicates that this difference in pharmacokinetics is also reflected in antimicrobial effect. CONCLUSION: Antibiotic concentrations are reduced significantly in ischemic lesions compared to those of healthy adipose tissue in patients with peripheral arterial occlusive disease. From the present data it might be speculated that improvement of arterial blood flow at the affected extremity is associated with increased cure rates of soft tissue infections in these patients. |
| | |
Authors:
|
C Joukhadar; N Klein; M Frossard; E Minar; H Stass; E Lackner; M Herrmann; E Riedmüller; M Müller |
Related Documents
:
|
10877419 - Percutaneous vascular intervention based on gadolinium-enhanced mr angiography. 9146719 - Percutaneous transluminal mesenteric angioplasty. 1511469 - Percutaneous transluminal coronary angioplasty of oversized saphenous coronary bypass g... 2527649 - Risk factors for recurrent stenosis following successful coronary angioplasty. 1867949 - Desirability of immediate surgical standby for coronary angioplasty. 8421339 - Transcutaneous ultrasonography can be used to guide and monitor balloon angioplasty. 16015439 - Gated blood pool spect for measurement of left ventricular volumes and left ventricular... 6853909 - Noninvasive evaluation of normal and abnormal prosthetic valve function. 2298589 - Early recognition of critical stenosis high in the left anterior descending coronary ar... |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Clinical pharmacology and therapeutics Volume: 70 ISSN: 0009-9236 ISO Abbreviation: Clin. Pharmacol. Ther. Publication Date: 2001 Dec |
Date Detail:
|
Created Date: 2001-12-25 Completed Date: 2002-01-15 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0372741 Medline TA: Clin Pharmacol Ther Country: United States |
Other Details:
|
Languages: eng Pagination: 532-9 Citation Subset: AIM; IM |
Affiliation:
|
Division of Clinical Pharmacokinetics, Department of Clinical Pharmacology, University of Vienna Medical School, Vienna, Austria. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adipose Tissue
/
metabolism Aged Aged, 80 and over Angioplasty* Anti-Infective Agents / adverse effects, pharmacokinetics*, pharmacology Area Under Curve Arterial Occlusive Diseases / metabolism*, surgery Chromatography, High Pressure Liquid Ciprofloxacin / adverse effects, pharmacokinetics*, pharmacology Female Half-Life Hemodynamics / physiology Humans Ischemia / metabolism Male Microbial Sensitivity Tests Microdialysis Middle Aged Vascular Surgical Procedures |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Infective Agents; 85721-33-1/Ciprofloxacin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Pharmacokinetics and metabolism of intravenous midazolam in preterm infants.
Next Document: QT interval lengthening in premature infants treated with doxapram.